REGN•benzinga•
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
Summary
Regeneron boosts antibody profits with higher Dupixent sales and expands biologics production via FUJIFILM Diosynth partnership.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2025 by benzinga